Universal-Beteiligungs- und Servicegesellschaft’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
283,333
+21
+0% +$724 0.02% 599
2026
Q1
$8.92M Buy
283,312
+11,927
+4% +$344K 0.02% 642
2025
Q4
$6.73M Buy
271,385
+138,882
+105% +$2.79M 0.01% 761
2025
Q3
$2.15M Buy
132,503
+325
+0.2% +$4.61K ﹤0.01% 1260
2025
Q2
$1.73M Buy
132,178
+42,753
+48% +$617K ﹤0.01% 1303
2025
Q1
$1.97M Sell
89,425
-606
-0.7% -$15.9K ﹤0.01% 1206
2024
Q4
$2.4M Buy
+90,031
New +$2.87M ﹤0.01% 862

Other funds holding EWTX

Universal-Beteiligungs- und Servicegesellschaft's EWTX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Edgewise Therapeutics (EWTX) stake by 0.01% in Q2 2026, buying an estimated $724 and bringing the position to 283,333 shares worth $11.5M. The position accounts for 0.02% of the portfolio, ranked #599.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in EWTX in Q4 2024 and has held it in 7 quarters since. 73 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 283,333 shares of Edgewise Therapeutics worth $11.5M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 21 Edgewise Therapeutics shares in Q2 2026, an estimated $724.
  • Edgewise Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #599 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 73 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.